RECRUITING

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.

Official Title

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Quick Facts

Study Start:2025-04
Study Completion:2027-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06880627

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have physician-diagnosis of Systemic sclerosis (SSc) (any subtype)
  2. * A score of ≥ 10 on the Perceived Deficits Questionnaire
  3. * A score of ≤ 7 on the 6-Item Cognitive Impairment Test
  4. * Have access to a reliable, internet-connected device (e.g. computer, smartphone, tablet)
  5. * Visual acuity with correction sufficient to work on a computer, smartphone, tablet or screen
  6. * Be able to read, speak, and understand English
  1. * Diagnosis of dementia or head injury
  2. * Other neurological disorders that might impact cognition
  3. * Have major psychiatric disorder such as major depression and schizophrenia
  4. * Complex, unstable health issues that would preclude full participation in the study (like a planned surgery or active cancer treatment)

Contacts and Locations

Study Contact

Elizabeth Haro, MPH
CONTACT
734-936-2123
elharo@umich.edu

Principal Investigator

Yen Chen, PhD
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Yen Chen, PhD, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04
Study Completion Date2027-06

Study Record Updates

Study Start Date2025-04
Study Completion Date2027-06

Terms related to this study

Keywords Provided by Researchers

  • Cognitive issues
  • Memory or Focus problems
  • Internet connected devices
  • Online group sessions
  • Online brain games
  • Surveys

Additional Relevant MeSH Terms

  • Scleroderma